Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery
Recruiting
N/A
Interventional Study
Morbid Obesity
Bariatric Surgery Candidate
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 20 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 162 (estimated)
- Sponsor
- Alexandria University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Rivaroxaban versus enoxaparin for prophylaxis of venous thromboembolism in morbidly obese patients undergoing bariatric surgery: An open\_label randomized controlled trial
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age: 20-60 years, both sexes.
* ASA physical status class I to III.
* BMI 35-50 kg/m²
Exclusion Criteria:
* Severe cardiac disorder
* chronic renal failure
* liver cirrhosis
* major psychological disorder
Contacts